BBLG MEXC RealStocks
Own real BBLG shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1

Last updated: 2026-11-16 04:01:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Bone Biologics Corp. (BBLG) operates in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector and is listed on NASDAQ. The stock is currently priced at $0.33, with a market capitalization of $1.10M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.32 to $2.39. This page covers its latest market performance, valuation, price trends and company information.
$1.10M | |
$0.37 | |
$0.39 | |
$0.33 | |
$0.40 | |
298.17K | |
261.60K | |
-- | |
$2.39 | |
$0.32 | |
-- | |
-- |
Bone Biologics Corp. (BBLG) last closed at $0.33 as of 2026-11-14 00:07:00, down 18.07% ($0.07) from the previous close of $0.40.
During the latest regular trading session, BBLG traded between $0.33 and $0.39, with a volume of 298.17K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Bone Biologics Corp. (BBLG) moved from $0.32 to $0.33, representing a gain of 0.71% ($0.00).
The stock traded between $0.32 and $0.48 during the period. The latest price is near the lower end of the 7-day range, indicating moderate upward.
The average daily volume was 1.24 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0.5%
BBLG is currently trading at $0.33, placing it 0.5% of the way from its 52-week low of $0.32 to its 52-week high of $2.39. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.
| Industry | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
| Employees | 2 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Bone Biologics Corp. (BBLG) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to BBLG, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between BBLG shares and USD.
BBLG Shares to USD
1.00 BBLG shares = 0.326 USD
Calculations are estimates based on the latest available price and are for reference only.